Ram Prasad Sahu In Mumbai

Stories by Ram Prasad Sahu In Mumbai

Gulf War: Stocks That Could Buck The Trend And Shine

Gulf War: Stocks That Could Buck The Trend And Shine

Rediff.com   1 hour ago

10 stocks from the Nifty 200 index that offer good growth potential and scope to deliver decent returns from current levels, based on brokerage estimates.

Hospital Stocks Poised for Strong Growth Despite West Asia War Worries

Hospital Stocks Poised for Strong Growth Despite West Asia War Worries

Rediff.com   2 hours ago

Despite initial pressure from the West Asia conflict, analysts are optimistic about the Indian hospital sector's outlook, citing strong demand drivers and ongoing expansion plans that are expected to fuel significant revenue growth over the next few years.

Gulf War: Stocks That Tanked The Most

Gulf War: Stocks That Tanked The Most

Rediff.com   3 hours ago

West Asia conflict triggers sharp sell-off in Indian markets, with realty, banking and auto stocks leading losses amid energy shock fears.

Earnings upgrade to downgrade ratio improved after Q3

Earnings upgrade to downgrade ratio improved after Q3

Rediff.com   3 Apr 2026

There are hopes of a turnaround in overall corporate earnings after six quarters of single digit growth.

Ola Electric hit by volume slump, market share loss as Q3 revenue plunges

Ola Electric hit by volume slump, market share loss as Q3 revenue plunges

Rediff.com   24 Feb 2026

Shares of electric vehicle (EV) maker Ola Electric Mobility fell nearly 7 per cent to a fresh low on Monday after its revenue growth in the third quarter (October-December/Q3) of 2025-26 (FY26) slowed, with analysts warning that any turnaround could be prolonged.

Nykaa's revival rests on more than just growth

Nykaa's revival rests on more than just growth

Rediff.com   17 Feb 2026

Strong performance in the beauty and personal care (BPC) segment, margin gains, and expectations of a breakeven in the fashion business lifted sentiment for FSN E-Commerce Ventures (Nykaa). The consumer technology platform's stock rose 7.5 per cent on Friday, extending gains over the past week to more than 17 per cent. Most brokerages have upgraded the stock following its third-quarter (October-December/Q3) performance and higher profit expectations ahead.

New launches to keep growth momentum healthy for Sun Pharma stock

New launches to keep growth momentum healthy for Sun Pharma stock

Rediff.com   13 Feb 2026

A strong third-quarter (October-December/Q3) performance for 2025-26 (FY26) has helped the stock of India's largest listed pharmaceutical (pharma) company, Sun Pharmaceutical Industries, gain about 7 per cent since the start of February.

10 Stocks That May Gain From Budget

10 Stocks That May Gain From Budget

Rediff.com   4 Feb 2026

The fiscal tilt towards capex benefits companies in investment-related sectors like capital goods, defence equipment, engineering & construction and metal & mining. The planned cut in revenue expenditure will weigh on companies in consumption sectors like FMCG, consumer durables and retail.

Smallcap To Watch Out For In 2026

Smallcap To Watch Out For In 2026

Rediff.com   4 Feb 2026

After two years of strong gains, smallcap stocks fell sharply in 2025, but the correction may be setting up opportunities for long-term investors.

Soft hiring trends keep Info Edge on back foot

Soft hiring trends keep Info Edge on back foot

Rediff.com   3 Feb 2026

Weakness in the information technology (IT) sector hiring has weighed on Info Edge (India) over the past year, leading to a 13 per cent correction in the stock during this period. While the company's 2025-26 (FY26) third-quarter (October-December/Q3) performance showed a marginal improvement, brokerages believe the IT hiring outlook remains weak due to macroeconomic uncertainty in the US.

Q3 revenue miss keeps Trent on back foot

Q3 revenue miss keeps Trent on back foot

Rediff.com   14 Jan 2026

Shares of apparel retail major Trent fell over 8.6 per cent to ~4,048 apiece at the close of trade on Tuesday. Trading near its 52-week low, the stock has shed about 43 per cent over the past year. Sentiment around the Tata group company weakened after it reported lower than expected revenue for the third quarter (October-December/Q3) of 2025-26 (FY26). Brokerages expect the stock to remain under pressure in the near term.

Value over volume for jewellery growth in H2

Value over volume for jewellery growth in H2

Rediff.com   9 Jan 2026

Jewellery makers are set to post strong revenue growth in the 2025-26 (FY26) October-December quarter (Q3), supported by a robust wedding season and rising value growth, even as volumes decline.

Tyre stocks to ride demand, margin tailwinds; global risks may bite

Tyre stocks to ride demand, margin tailwinds; global risks may bite

Rediff.com   5 Jan 2026

Shares of tyre manufacturers have outperformed broader equity benchmarks, buoyed by multiple tailwinds. Softer raw material prices, an uptick in demand from automakers following the reduction of the goods and services tax (GST) rates, and steady replacement demand have lifted sentiment toward the sector.

Margin, valuation worries may weigh on Eicher stock

Margin, valuation worries may weigh on Eicher stock

Rediff.com   2 Jan 2026

The stock of automative major Eicher Motors hit its all-time high on Wednesday, capping the year with gains of about 52.7 per cent. It has comfortably outperformed its sector index, the Nifty Auto, which jumped 22.7 per cent, as well as the benchmark Nifty, which rose 10 per cent during this period.

Volume, margin concerns likely to weigh on beer maker United Breweries

Volume, margin concerns likely to weigh on beer maker United Breweries

Rediff.com   27 Dec 2025

The stock of the country's largest beer maker, United Breweries (UBBL), is trading at 25-month lows given multiple headwinds related to volumes, regulatory issues, and margin trajectory. After a muted second quarter (July-September) of 2025-26 (Q2FY26), brokerages also expect the company's Q3FY26 performance to be underwhelming.

Max Healthcare builds growth runway with brownfield expansion push

Max Healthcare builds growth runway with brownfield expansion push

Rediff.com   29 Nov 2025

Healthcare major Max Healthcare Institute delivered a healthy performance in the second quarter (July-September) of 2025-26 (Q2FY26). Strong patient volumes and average revenues not only boosted the top line but also aided the operating performance.

Non-auto segments to drive growth for Bharat Forge

Non-auto segments to drive growth for Bharat Forge

Rediff.com   27 Nov 2025

The stock of automotive (auto) components major Bharat Forge has risen 14.6 per cent over the past month. Despite ongoing demand challenges, strong operating performance in the July-September quarter (Q3) of 2025-26 (FY26), a diversified revenue base, and expectations of a gradual recovery have lifted sentiment.

Many growth triggers for Samvardhana Motherson

Many growth triggers for Samvardhana Motherson

Rediff.com   22 Nov 2025

The country's largest listed auto parts company by market capitalisation, Samvardhana Motherson International, reported a better than expected operating performance in the second quarter (July-September) of 2025-26 (Q2FY26). Though the global passenger vehicle (PV) market is facing multiple headwinds, the company is outperforming on the back of higher content per vehicle and market share gains.

IT recovery key for Info Edge as Q2 growth lags on weak hiring trends

IT recovery key for Info Edge as Q2 growth lags on weak hiring trends

Rediff.com   21 Nov 2025

Hit by a slowdown in information technology (IT) hiring, Info Edge (India)'s results for the July-September quarter (Q2) of 2025-26 (FY26) fell short of brokerage expectations. What helped the online recruitment major offset the weak IT hiring trend was broad-based growth across other sectors.

Strong therapies, JB to lift Torrent Pharma

Strong therapies, JB to lift Torrent Pharma

Rediff.com   18 Nov 2025

A strong performance in the July-September quarter of 2025-26 (FY26) and expectations of growth from launches and acquisition-led synergies led to a 6.65 per cent jump in the share price of Torrent Pharmaceuticals.